HUP0100832A3 - Quinoxaline and quinoline carboxamide derivatives, their use and the pharmaceutical compositions containing them - Google Patents
Quinoxaline and quinoline carboxamide derivatives, their use and the pharmaceutical compositions containing themInfo
- Publication number
- HUP0100832A3 HUP0100832A3 HU0100832A HUP0100832A HUP0100832A3 HU P0100832 A3 HUP0100832 A3 HU P0100832A3 HU 0100832 A HU0100832 A HU 0100832A HU P0100832 A HUP0100832 A HU P0100832A HU P0100832 A3 HUP0100832 A3 HU P0100832A3
- Authority
- HU
- Hungary
- Prior art keywords
- quinoxaline
- pharmaceutical compositions
- compositions containing
- carboxamide derivatives
- quinoline carboxamide
- Prior art date
Links
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- ZEXKKIXCRDTKBF-UHFFFAOYSA-N quinoline-2-carboxamide Chemical class C1=CC=CC2=NC(C(=O)N)=CC=C21 ZEXKKIXCRDTKBF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7380198P | 1998-02-05 | 1998-02-05 | |
| PCT/IB1999/000067 WO1999040061A2 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0100832A2 HUP0100832A2 (hu) | 2002-02-28 |
| HUP0100832A3 true HUP0100832A3 (en) | 2002-03-28 |
Family
ID=22115885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0100832A HUP0100832A3 (en) | 1998-02-05 | 1999-01-18 | Quinoxaline and quinoline carboxamide derivatives, their use and the pharmaceutical compositions containing them |
Country Status (36)
| Country | Link |
|---|---|
| EP (1) | EP1051405B1 (OSRAM) |
| JP (1) | JP3693916B2 (OSRAM) |
| KR (1) | KR100385529B1 (OSRAM) |
| CN (1) | CN1177834C (OSRAM) |
| AP (1) | AP992A (OSRAM) |
| AR (1) | AR016175A1 (OSRAM) |
| AT (1) | ATE337307T1 (OSRAM) |
| AU (1) | AU752407B2 (OSRAM) |
| BG (1) | BG104726A (OSRAM) |
| BR (1) | BR9907655A (OSRAM) |
| CA (1) | CA2320388C (OSRAM) |
| DE (1) | DE69932920T2 (OSRAM) |
| DZ (1) | DZ2717A1 (OSRAM) |
| EA (1) | EA003137B1 (OSRAM) |
| ES (1) | ES2268847T3 (OSRAM) |
| GT (1) | GT199900011A (OSRAM) |
| HR (1) | HRP20000529B1 (OSRAM) |
| HU (1) | HUP0100832A3 (OSRAM) |
| IL (1) | IL137330A0 (OSRAM) |
| IS (1) | IS5562A (OSRAM) |
| MA (1) | MA26603A1 (OSRAM) |
| MY (1) | MY133125A (OSRAM) |
| NO (1) | NO20003965D0 (OSRAM) |
| NZ (1) | NZ505724A (OSRAM) |
| OA (1) | OA11448A (OSRAM) |
| PA (1) | PA8467301A1 (OSRAM) |
| PE (1) | PE20000243A1 (OSRAM) |
| PL (1) | PL342817A1 (OSRAM) |
| SK (1) | SK11262000A3 (OSRAM) |
| TN (1) | TNSN99013A1 (OSRAM) |
| TR (1) | TR200002248T2 (OSRAM) |
| TW (1) | TW470744B (OSRAM) |
| UA (1) | UA57824C2 (OSRAM) |
| WO (1) | WO1999040061A2 (OSRAM) |
| YU (1) | YU47100A (OSRAM) |
| ZA (1) | ZA99873B (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2862300A (en) * | 1999-01-29 | 2000-08-18 | Millennium Pharmaceuticals, Inc. | Methods for preventing graft rejection and ischemia-reperfusion injury |
| BR0013469B1 (pt) * | 1999-08-20 | 2011-01-25 | amidas aromáticas heterocìclicas fungicidas, composição fungicida compreendendo as mesmas, bem como método para o controle ou a prevenção de infestação fúngica. | |
| UA72789C2 (en) | 2000-02-04 | 2005-04-15 | Pfizer Prod Inc | Heterocyclic amide derivatives |
| EP1498417A1 (en) * | 2000-02-04 | 2005-01-19 | Pfizer Products Inc. | Heterocyclic amide derivatives |
| US6740636B2 (en) | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| US6746856B2 (en) | 2000-08-09 | 2004-06-08 | Pfizer Inc. | Microbial conversion of bicyclic heteroaromatic compounds |
| JP4547148B2 (ja) | 2001-06-22 | 2010-09-22 | ベンド・リサーチ・インコーポレーテッド | 非晶質薬剤の吸着物の医薬組成物 |
| EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| MXPA03011784A (es) * | 2001-06-22 | 2004-04-02 | Pfizer Prod Inc | Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros. |
| DE10152351B4 (de) * | 2001-10-18 | 2005-09-22 | Schering Ag | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
| WO2003063833A1 (en) | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| CA2484342A1 (en) * | 2002-05-14 | 2003-11-20 | Pfizer Products Inc. | Methods for manufacture of dihydro-furan-2-one derivatives |
| JP2005530775A (ja) * | 2002-05-14 | 2005-10-13 | ファイザー・プロダクツ・インク | ジヒドロキシヘキサン酸誘導体、それらの中間体、および製法 |
| AU2003249474A1 (en) | 2002-08-12 | 2004-02-25 | Pfizer Products Inc. | Pharmaceutical compositions of semi-ordered drugs and polymers |
| MXPA05001781A (es) * | 2002-08-12 | 2005-04-25 | Pfizer Prod Inc | Formas cristalinas de [4-carbamoil -1-(3- fluorobencil)-2, 7-dihidroxi- 7-metil- octil]-amida del acido quinoxalina-2- carboxilico. |
| US20040097554A1 (en) * | 2002-10-30 | 2004-05-20 | Pfizer Inc | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents |
| US20040087571A1 (en) * | 2002-10-30 | 2004-05-06 | Pfizer Inc | Methods of using CCR1 antagonists as immunomodulatory agents |
| MXPA06001417A (es) | 2003-08-04 | 2006-05-15 | Pfizer Prod Inc | Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923864A (en) * | 1987-12-15 | 1990-05-08 | Pfizer Inc. | Certain heterocyclic-hexanamides useful for treating hypertension |
| PT708085E (pt) * | 1994-10-19 | 2002-11-29 | Novartis Ag | Eteres antivirais de isosteros de substrato de aspartato protease |
| DE19708106A1 (de) * | 1997-02-28 | 1998-09-03 | Bosch Gmbh Robert | Einrichtung und Verfahren zur Information über Verkehrsstörungen |
-
1999
- 1999-01-18 TR TR2000/02248T patent/TR200002248T2/xx unknown
- 1999-01-18 BR BR9907655-1A patent/BR9907655A/pt not_active Application Discontinuation
- 1999-01-18 EP EP99900098A patent/EP1051405B1/en not_active Expired - Lifetime
- 1999-01-18 CN CNB998027138A patent/CN1177834C/zh not_active Expired - Fee Related
- 1999-01-18 AT AT99900098T patent/ATE337307T1/de not_active IP Right Cessation
- 1999-01-18 AU AU17789/99A patent/AU752407B2/en not_active Ceased
- 1999-01-18 PL PL99342817A patent/PL342817A1/xx not_active Application Discontinuation
- 1999-01-18 WO PCT/IB1999/000067 patent/WO1999040061A2/en not_active Ceased
- 1999-01-18 EA EA200000741A patent/EA003137B1/ru not_active IP Right Cessation
- 1999-01-18 CA CA002320388A patent/CA2320388C/en not_active Expired - Fee Related
- 1999-01-18 JP JP2000530493A patent/JP3693916B2/ja not_active Expired - Lifetime
- 1999-01-18 HR HR20000529 patent/HRP20000529B1/xx not_active IP Right Cessation
- 1999-01-18 SK SK1126-2000A patent/SK11262000A3/sk unknown
- 1999-01-18 DE DE69932920T patent/DE69932920T2/de not_active Expired - Lifetime
- 1999-01-18 ES ES99900098T patent/ES2268847T3/es not_active Expired - Lifetime
- 1999-01-18 HU HU0100832A patent/HUP0100832A3/hu unknown
- 1999-01-18 NZ NZ505724A patent/NZ505724A/xx unknown
- 1999-01-18 KR KR10-2000-7008561A patent/KR100385529B1/ko not_active Expired - Fee Related
- 1999-01-18 IL IL13733099A patent/IL137330A0/xx unknown
- 1999-01-18 PA PA19998467301A patent/PA8467301A1/es unknown
- 1999-01-18 UA UA2000074534A patent/UA57824C2/uk unknown
- 1999-01-18 YU YU47100A patent/YU47100A/sh unknown
- 1999-01-27 GT GT199900011A patent/GT199900011A/es unknown
- 1999-02-01 PE PE1999000071A patent/PE20000243A1/es not_active Application Discontinuation
- 1999-02-01 TW TW088101505A patent/TW470744B/zh not_active IP Right Cessation
- 1999-02-03 DZ DZ990018A patent/DZ2717A1/xx active
- 1999-02-03 MA MA25448A patent/MA26603A1/fr unknown
- 1999-02-03 MY MYPI99000363A patent/MY133125A/en unknown
- 1999-02-03 TN TNTNSN99013A patent/TNSN99013A1/fr unknown
- 1999-02-03 AR ARP990100443A patent/AR016175A1/es unknown
- 1999-02-04 ZA ZA9900873A patent/ZA99873B/xx unknown
- 1999-02-04 AP APAP/P/1999/001457A patent/AP992A/en active
-
2000
- 2000-07-14 IS IS5562A patent/IS5562A/is unknown
- 2000-07-28 OA OA1200000214A patent/OA11448A/en unknown
- 2000-08-04 NO NO20003965A patent/NO20003965D0/no not_active Application Discontinuation
- 2000-08-29 BG BG104726A patent/BG104726A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104725A3 (en) | Quinoline and quinoxaline compounds, medicaments containing them and their use | |
| HUP0105133A3 (en) | Quinoline derivatives and quinazoline derivatives, pharmaceutical compositions containing them and their use | |
| HUP0100941A3 (en) | Quinoline, quinazoline and pyrido-pyrimidine derivatives and pharmaceutical compositions thereof | |
| HUP0301146A3 (en) | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use | |
| HUP0200312A3 (en) | Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use | |
| HUP0102766A3 (en) | Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them | |
| IL138573A0 (en) | Amide derivatives and pharmaceutical compositions containing the same | |
| IL138899A0 (en) | Amidene derivatives and pharmaceutical compositions containing the same | |
| IL152490A0 (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| IL140862A (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the same | |
| HUP0400540A3 (en) | 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them | |
| IL151952A0 (en) | Aminopyridine derivatives and pharmaceutical compositions containing the same | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
| IL143920A0 (en) | 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0103590A3 (en) | Nucleophile substituted ecteinascidins and n-oxide ecteinascidins, the pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0105073A3 (en) | 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them | |
| HUP0203645A3 (en) | Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use | |
| IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
| ZA991590B (en) | Indole derivatives and pharmaceutical compositions comprising the same. | |
| HUP0105075A3 (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them | |
| IL137415A0 (en) | Cyclobutene derivatives and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |